Navigation Links
Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting
Date:5/26/2009

Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.

Cautionary Note for Forward-Looking Statements. This press release contains forward-looking statements that reflect the Company's current expectations about its prospects and opportunities. The Company has tried to identify these forward looking statements by using words such as "expect," "anticipate," "estimate," "plan," "will," "would," "forecast," "believe," "guidance," "projection" or similar expressions, but these words are not the exclusive means for identifying such statements. The Company cautions that a number of risks, uncertainties and other important factors could cause the Company's actual results to differ materially from those in the forward-looking statements including, without limitation, current economic conditions, foreign currency fluctuations, risks associated with the Company's continued research and development efforts with respect to the endovascular products (including the risk that those efforts will not be successful and that some of the associated milestone payments will not be received) and Spectranetics' success in selling the ThromCat(TM) and SafeCross(TM) products, as well as the Company's success in distributing its products into the marketplace, the Company's dependence on four major customers (St. Jude Medical, Arthrex, Orthovita and Spectranetics) and their success in selling Kensey Nash related products in the marketplace, the impact of product recalls and other manufacturing issues, and competition from other technologies. For a detailed discussion of factors that could affect the Company's future operating results, please see the Company's SEC filings, including the disclosure under "Risk Factors" in those filings. Except as expressly required by the federal securities laws, the Company undertakes no obligat
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Kensey Nash Announces IDE Submission for Cartilage Repair Device
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)...  New guidelines released today by the American ... for better outcomes to the hundreds of thousands ... each year. Stryker,s Trevo ® Retriever was ... clinical trials that provided data for this development. ... endovascular therapy with stent retrievers for ischemic stroke ...
(Date:6/29/2015)... 29, 2015  Allergan plc (NYSE: AGN ... second quarter 2015 financial results on Thursday, August ... U.S. financial markets. The Company will host a conference ... Time on Thursday, August 6, 2015 to discuss ... call is U.S./ Canada (877) ...
(Date:6/29/2015)... 2015 Axxess , an industry leader ... software vendor accredited by the American Nursing Credentialing Center ... health agencies select the right revenue cycle management (RCM) ... their business. Research by American Health Information ... expect a decrease in productivity of 54.4 - 69 ...
Breaking Medicine Technology:New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 2Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2
... CRDC ) today announced that Bernard A. Hausen, M.D., ... present a corporate overview and update at the following conferences: ... November 15, 2011 8:00 a.m. ET New York, NY ... 2011 9:30 a.m. New York, NY To access the ...
... 10, 2011 The Medical Oncology Association of ... recently signed an agreement to work together to ... quality and costs of cancer care in Southern ... clinical, reimbursement and distribution services to help health ...
Cached Medicine Technology:Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care 2Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care 3
(Date:6/29/2015)... ... June 29, 2015 , ... World Patent Marketing, a vertically ... baby invention that makes parenthood less tiring without sacrificing your child's well being. ... of USD 52.2 billion in 2017," says Scott Cooper, CEO and Creative Director ...
(Date:6/29/2015)... PA (PRWEB) , ... June 29, 2015 , ... People across the country give their ... gift-giving is part of our culture. , But, how often do coworkers donate “life” ... kidney was a simple one. , “Dawna (Wright-Thompson) told me her husband was ...
(Date:6/29/2015)... ... 29, 2015 , ... With Urgent Care Medicine now serving a vital role ... of Urgent Care Medicine and the Medical Society of Delaware to provide its latest ... and health care professionals. , According to Matthew Bader, Exam Master CEO and President, ...
(Date:6/29/2015)... ... June 29, 2015 , ... San Fernando Valley ... and tighten sagging skin. Ulthera is a special treatment that offers a way to ... technology to gently stimulate collagen production. Ulthera is highly targeted and precise to help ...
(Date:6/29/2015)... ... June 29, 2015 , ... New research released ... than 10 percent of U.S. state and local governments have implemented Next Generation ... deadline for NG9-1-1. , “Mobile phones have surpassed land lines as the ...
Breaking Medicine News(10 mins):Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 2Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 3Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 4Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 5Health News:VA Pittsburgh Employee Donates Kidney to Coworker’s Spouse 2Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 2Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 3Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 2Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 4
... With dental disease among pre-schoolers on the rise, ... in a national campaign to extend necessary care to ... the seventh annual ADA Give Kids A Smile(R) program, ... as many as 500,000 children at more than 1,600 ...
... Ill., Feb. 2 The Journal of ... results demonstrating,Hospira, Inc.,s (NYSE: HSP ... sedation provides comparable effectiveness to,commonly used gamma-aminobutyric ... ventilated patients in the,intensive care unit (ICU). ...
... Arthroscopic surgery for athletes greatly reduces risk of recurring ... News) -- Surgery to repair a young athlete,s dislocated ... according to experts who looked at two types of ... teens. , "Studies show that performing arthroscopic surgery to ...
... Approach $900 Million by 2013, According to Millennium Research ... PR Newswire, we are advised by the company that ... $300 Million by 2013" rather than "$900 Million." ... sentence should read "...is expected to approach $300 million ...
... Fla., Feb. 2 Cosmetic Bootcamp LLC,announces strong ... and,fellows in the core esthetic specialties of dermatology, ... "Sole commercial sponsorship from Allergan Medical and ... Allergan (AGN) have enabled us,to plan to bring ...
... Using a special MRI technique, researchers have determined that the ... asthma sufferers can be markedly persistent over time. The findings ... . , "A considerable number of airways appeared to ... Eduard E. de Lange, M.D., professor of radiology at the ...
Cached Medicine News:Health News:ADA 'Give Kids A Smile' Events Provide Dental Care to Children from Low-Income Families 2Health News:Hospira's Precedex(R) Phase IV Study Published in the Journal of the American Medical Association 2Health News:Hospira's Precedex(R) Phase IV Study Published in the Journal of the American Medical Association 3Health News:Hospira's Precedex(R) Phase IV Study Published in the Journal of the American Medical Association 4Health News:Quick Orthopedic Repair Can Save Young Shoulders 2Health News:Thrombectomy Device Market to Approach $300 Million by 2013, According to Millennium Research Group 2Health News:Thrombectomy Device Market to Approach $300 Million by 2013, According to Millennium Research Group 3Health News:Cosmetic Bootcamp LLC Affirms Plans for University and Summer Symposia 2Health News:Even with medication, asthma patients show chronic airflow changes in lungs 2
... A concentrated enzymatic cleanser ... semi-automated hematology instruments. It ... all Abbott CELL-DYN® hematology ... instruments. The shelf life ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Medicine Products: